Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model
Diseases | Free Full-Text | Progress and Perspectives in Colon Cancer Pathology, Diagnosis, and Treatments
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial - The Lancet Oncology
4. Cancer colorectal métastatique | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive
Xeloda: Package Insert / Prescribing Information - Drugs.com
Effects of bevacizumab (Avastin ® ) and capecitabine (Xeloda ® ) on the... | Download Scientific Diagram
Avastin with Xeloda as a first-line treatment for metastatic breast cancer | PDF
Avastin ® : setting the standard in treatment for metastatic colorectal cancer (CRC) Fairooz Kabbinavar David Geffen School of Medicine at UCLA Los Angeles, - ppt download
Maintenance Treatment With Capecitabine and Bevacizumab Is Effective in Metastatic Colorectal Cancer - The ASCO Post
Xeloda – Treatment for Metastatic Colorectal Cancer - Clinical Trials Arena
1175-Colorectal metastatic capecitabine and beVACizumab | eviQ
Xeloda: Package Insert / Prescribing Information - Drugs.com
Cancers | Free Full-Text | Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer
Xeloda – Treatment for Metastatic Colorectal Cancer - Clinical Trials Arena
Phase III studies of Xeloda® in colorectal cancer (CRC) - ppt download
Effects of bevacizumab (Avastin ® ) and capecitabine (Xeloda ® ) on the... | Download Scientific Diagram
PPT - Xeloda: simplifying the complexity of treatment for metastatic colorectal cancer (MCRC) PowerPoint Presentation - ID:3905318
Avastin with Xeloda as a first-line treatment for metastatic breast cancer | PDF
Bevacizumab in First-line Therapy of Metastatic Colorectal Cancer: A Retrospective Comparison of FOLFIRI and XELIRI | Anticancer Research
PPT - Xeloda: simplifying the complexity of treatment for metastatic colorectal cancer (MCRC) PowerPoint Presentation - ID:3905318
Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives - ScienceDirect
Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study | Journal of Clinical Oncology
Xeloda – Treatment for Metastatic Colorectal Cancer - Clinical Trials Arena
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial - The Lancet Oncology
Xeloda: Package Insert / Prescribing Information - Drugs.com
